
Neurosoft Bioelectronics builds minimally invasive soft brain interfaces to monitor, treat, and restore function in people with neurological disorders. The company manufactures ultra-soft, elastic implantable electrodes (SOFT ECoG™, MINDZ™, SOFT TINNIT™, Synapsuit) that conform to neural tissue and reduce scarring using semiconductor-industry manufacturing processes under ISO 13485 and GMP practices. It integrates Artificial Intelligence to analyze neural recordings for biomarker detection, neuromodulation optimization, and decoding motor and speech intentions. Neurosoft is a MedTech deeptech company developing investigational Brain-Computer Interface products for clinical research and therapeutic use.

Neurosoft Bioelectronics builds minimally invasive soft brain interfaces to monitor, treat, and restore function in people with neurological disorders. The company manufactures ultra-soft, elastic implantable electrodes (SOFT ECoG™, MINDZ™, SOFT TINNIT™, Synapsuit) that conform to neural tissue and reduce scarring using semiconductor-industry manufacturing processes under ISO 13485 and GMP practices. It integrates Artificial Intelligence to analyze neural recordings for biomarker detection, neuromodulation optimization, and decoding motor and speech intentions. Neurosoft is a MedTech deeptech company developing investigational Brain-Computer Interface products for clinical research and therapeutic use.
What they do: Develop minimally invasive, ultra-soft implantable brain interfaces and AI tools for neural data
Founded / HQ: 2020; Campus Biotech, Geneva, Switzerland (EPFL spin-off)
Notable milestone: First-in-human test of a 64-channel soft cortical interface during epilepsy surgery (27 Feb 2025)
Team / founders: Nicolas Vachicouras (CEO), Ludovic Serex (CTO), Florian Fallegger (Co‑founder) — Prof. Stéphanie Lacour listed as co‑founder
Funding signal: Multiple institutional supporters and investors including Kickfund, Innosuisse, European Innovation Council
Neurological disorders diagnosis, monitoring, and treatment; brain–computer interfaces for restoring or augmenting neural function.
2020
Biotechnology
Crunchbase lists Kickfund as lead for the Seed round
3181630 USD
Aggregate funding amount reported on company profile metadata
“Backed by institutional supporters and investors including European Innovation Council, FONGIT, Innosuisse, Kickfund, MassChallenge, Plug and Play, Venture Kick”